DAVID ETZEL: Open Payments
NPI 1881999555 · SHELBY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 51 payments from 11 companies in 2025. Trend: 2023 $827 · 2024 $233 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $290 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $156 |
| AstraZeneca Pharmaceuticals LP | 8 | $153 |
| Xeris Pharmaceuticals, Inc. | 3 | $48 |
| Alkermes, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $33 |
| PFIZER INC. | 2 | $33 |
| Abbott Laboratories | 2 | $33 |
| Dexcom, Inc. | 1 | $30 |
| Indivior Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, BREZTRI, UBRELVY, GVOKE HYPOPEN, VIVITROL, AIRSUPRA, Ozempic.
Industry payments across OH — which companies pay providers there.
